An in-vivo study of the integrity of the nigrostriatal pathways in drug-naive Parkinson's disease patients using [11C]PE2I PET and neuromelanin-Magnetic Resonance Imaging

被引：0
|
作者：
Pagano, G.
Wilson, H.
de Natale, E.
Niccolini, F.
Polychronis, S.
Yousaf, T.
Gunn, R.
Rabiner, E.
Mehta, M.
Politis, M.
机构：
来源：
MOVEMENT DISORDERS | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1596
引用
收藏
页码：S704 / S704
页数：1
相关论文
共 33 条
  • [1] [11C]PHNO and [11C]racloride PET imaging of dopamine receptors in drug-naive Parkinson's disease
    Boileau, Isabelle
    Guttman, Mark
    Houle, Sylvain
    Rusjan, Pablo
    Wilson, Alan A.
    Kapur, Shitij
    Kish, Stephen J.
    BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 228S - 228S
  • [2] Imaging Parkinson's disease pathology: A comparison between neuromelanin-sensitive MRI, susceptibility weighted imaging and [11C]PE2I DAT PET
    Chandra, A.
    Pagano, G.
    Yousaf, T.
    Wilson, H.
    Politis, M.
    MOVEMENT DISORDERS, 2019, 34 : S133 - S133
  • [3] Imaging nigrostriatal circuitry with 11C-PE2I PET and neuromelanin-sensitive MR in Parkinson's disease
    Bastida, A. Martin
    Lao-Kaim, N.
    Roussakis, A. -A.
    Politis, M.
    Li, W.
    Valle-Guzman, N.
    Kefalopoulou, Z.
    Paul, G.
    Widner, H.
    Foltynie, T.
    Barker, R.
    Piccini, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 920 - 920
  • [4] Multimodal imaging assessment of nigrostriatal pathway in Parkinson's disease using 11C-PE2I PET and neuromelanin-sensitive MR
    Martin-Bastida, A.
    Lao-Kaim, N. P.
    Roussakis, A. A.
    Li, W.
    Politis, M.
    Valle-Guzman, N.
    Kefalopoulou, Z.
    Paul, G.
    Widner, H.
    Foltynie, T.
    Barker, R.
    Piccini, P.
    MOVEMENT DISORDERS, 2016, 31 : S408 - S409
  • [5] Dopamine transporter binding in patients with juvenile myoclonic epilepsy using [11C]PE2I and PET
    Odano, Ikuo
    Varrone, Andrea
    Ciumas, Carolina
    Jucaite, Aurelija
    Halldin, Christer
    Farde, Lars
    Savic, Ivanka
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [6] Parkinson’s disease laterality: a 11C-PE2I PET imaging study
    Andreas-Antonios Roussakis
    Zhou Zeng
    Nicholas P. Lao-Kaim
    Antonio Martin-Bastida
    Paola Piccini
    Journal of Neurology, 2021, 268 : 582 - 589
  • [7] Parkinson's disease laterality: a11C-PE2I PET imaging study
    Roussakis, Andreas-Antonios
    Zeng, Zhou
    Lao-Kaim, Nicholas P.
    Martin-Bastida, Antonio
    Piccini, Paola
    JOURNAL OF NEUROLOGY, 2021, 268 (02) : 582 - 589
  • [8] Longitudinal combined 11C UCB J and 18F FE PE2I PET imaging of presynaptic terminal loss in early Parkinson's disease
    Delva, A.
    Van Laere, K.
    Vandenberghe, W.
    MOVEMENT DISORDERS, 2022, 37 : S67 - S67
  • [9] Comparison between [11C]PE2I PET and [123I]FP-CIT SPECT as markers of DAT expression in early Parkinson's disease
    Yousaf, T.
    Pagano, G.
    Wilson, H.
    Corcoran, B.
    Vivian, G.
    Politis, M.
    MOVEMENT DISORDERS, 2019, 34 : S842 - S842
  • [10] Striatal Dopaminergic Metabolism and DAT Density in Young Onset Parkinson's Disease Patients: a PET Study with [18F]fluoro-L-DOPA and [11C]PE2I Using Two Methods of Analysis
    Santiago-Ribeiro, M. J.
    Lohmann, E.
    Brice, A.
    Dolle, F.
    Laurier, L.
    Syrota, A.
    Remy, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S57 - S58
1234